Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Koh

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Science Translational Medicine|March 18, 2026
Amyloid-β as a target to suppress tonic PTH hypersecretion in hyperparathyroidism due to vitamin D deficiencyChia-Ling Tu, Zhiqiang Cheng, Nicholas Szeto, et al.
The Breast Journal|June 27, 2007
Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifenHyman B Muss, Janice Yanushka Bunn, Abigail Crocker, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2011
Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptorJames Koh, Moahad Dar, Brian R Untch, et al.
The Lancet Regional Health. Europe|February 3, 2026
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across EuropeIrene López-Sánchez, Anna Palomar-Cros, Ravinder Claire, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Science Translational Medicine|March 18, 2026
Amyloid-β as a target to suppress tonic PTH hypersecretion in hyperparathyroidism due to vitamin D deficiencyChia-Ling Tu, Zhiqiang Cheng, Nicholas Szeto, et al.
The Breast Journal|June 27, 2007
Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifenHyman B Muss, Janice Yanushka Bunn, Abigail Crocker, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2011
Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptorJames Koh, Moahad Dar, Brian R Untch, et al.
The Lancet Regional Health. Europe|February 3, 2026
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across EuropeIrene López-Sánchez, Anna Palomar-Cros, Ravinder Claire, et al.
Pageof 3